ADXS
Advaxis, Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Advaxis, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Lm-based antigen delivery products. These immunotherapies are based on a platform technology that utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. These Lm-based strains are believed to be a significant advancement in immunotherapy as they integrate multiple functions into a single immunotherapy and are designed to access and direct antigen presenting cells to stimulate anti-tumor T cell immunity, activate the immune system with the equivalent of multiple adjuvants, and simultaneously reduce tumor protection in the tumor microenvironment to enable T cells to eliminate tumors.
Market Cap: 42.9 Million
Primary Exchange: NASDAQ
Website: www.advaxis.com
Shares Outstanding: 146 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 1.318149506642875
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 1794 trading days
From: 2015-06-01 To: 2021-12-22
Lowest Point:
Advaxis, Inc. (ADXS) CEO Kenneth Berlin on Q2 2019 Results - Earnings Call Transcript
via: SeekingAlpha at 2019-06-11 10:53:04:000
Advaxis, Inc. (ADXS) Q2 2019 Earnings Conference Call June 11, 2019 11:00 A.M. ET Company Participants Yvonne Briggs - Vice President, LHA Kenneth Berlin - President and Chief Executive Officer Andres Gutierrez - Executive Vice President and Chief Medical Officer Molly Henderso… read more...
Advaxis, Inc. (ADXS) CEO Kenneth Berlin on Q2 2019 Results - Earnings Call Transcript
via: SeekingAlpha at 2019-06-11 10:53:04:000
Advaxis, Inc. (ADXS) Q2 2019 Earnings Conference Call June 11, 2019 11:00 A.M. ET Company Participants Yvonne Briggs - Vice President, LHA Kenneth Berlin - President and Chief Executive Officer Andres Gutierrez - Executive Vice President and Chief Medical Officer Molly Henderso… read more...
Advaxis, Inc. (ADXS) CEO Kenneth Berlin on Q2 2019 Results - Earnings Call Transcript
via: SeekingAlpha at 2019-06-11 10:53:04:000
Advaxis, Inc. (ADXS) Q2 2019 Earnings Conference Call June 11, 2019 11:00 A.M. ET Company Participants Yvonne Briggs - Vice President, LHA Kenneth Berlin - President and Chief Executive Officer Andres Gutierrez - Executive Vice President and Chief Medical Officer Molly Henderso… read more...
Caseys General Stores among after hour gainers
via: SeekingAlpha at 2019-06-10 13:38:05:000
Gainers: NBY +20.3% . CASY +9.4% . KEG +3.5% . CHAP +3.2% . CXW +2.7% . More news on: NovaBay Pharmaceuticals, Inc., Casey's General Stores, Inc., Key Energy Services, Inc., Stocks on the move, , News on ETFs Read more … read more...
Advaxis  EPS misses by $0.02, beats on revenue
via: SeekingAlpha at 2019-06-10 12:08:10:000
Advaxis (NASDAQ: ADXS ): Q2 GAAP EPS of -$1.59 misses by $0.02 . More news on: Advaxis, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more … read more...
Advaxis Reports Second Quarter Fiscal 2019 Financial Results and Provides Pipeline Update
via: Business Wire at 2019-06-10 12:05:00:000
Conference call to be held June 11 at 11:00 a.m. ET Advaxis, Inc. (NASDAQ:ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced an update on its clinical pipeline and financial results … read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|